Mr Chiminski will also serve as a member of the board of directors of Catalent. George Fotiades, who has been serving as president and CEO on an interim basis, will step down from the role effective the same date, but will continue to serve as chairman of Catalent’s board of directors.
Mr Chiminski most recently served as the president and CEO of GE Medical Diagnostics, a developer of diagnostic imaging agents.
Mr Fotiades said: “I am pleased to welcome John to the Catalent executive team. He is an exceptional leader with a passion for serving the customer. His proven track record in innovation, operational excellence and achieving superior performance with global businesses is ideally suited to driving Catalent to reach its full potential.”